MetaADEDB 2.0 @ LMMD
zolmitriptan
(ULSDMUVEXKOYBU-ZDUSSCGKSA-N)
Structure
SMILES
CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C
Type(s)
Approved; Investigational
ATC code(s)
N02CC03
Molecular Formula:
C16H21N3O2
Molecular Weight:
287.357
Log P:
2.2517
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
57.36
CAS Number(s):
139264-17-8; 139264-25-8
Synonym(s)
1.
zolmitriptan
2.
311C90
3.
4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone
4.
AscoTop
5.
Flezol
6.
Zomig
7.
Zomigoro
External Link(s)
MeSHC089750
PubChem Compound60857
BindingDB50033383
ChEBI10124
CHEMBLCHEMBL1185
DrugBankDB00315
DrugCentral2869
IUPHAR/BPS Guide to PHARMACOLOGY60
KEGGcpd:C07218
dr:D00415
Therapeutic Target DatabaseD0NG7O
ZINC15515
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug dose omissionFAERS: 240OFFSIDES
US FAERS
2HeadacheFAERS: 166SIDER
US FAERS
3Drug ineffectiveFAERS: 90
Canada Vigilance: 28
Canada Vigilance
US FAERS
4MalaiseFAERS: 81
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
5VomitingFAERS: 77
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
6Intentional drug misuseFAERS: 58US FAERS
7NauseaFAERS: 48
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8PainFAERS: 4815836966
16239765
CTD
OFFSIDES
SIDER
US FAERS
9Feeling abnormalFAERS: 32SIDER
US FAERS
10NasopharyngitisFAERS: 29US FAERS
11DizzinessFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
12FatigueFAERS: 24
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
13DysgeusiaFAERS: 19OFFSIDES
SIDER
US FAERS
14Incorrect dose administeredFAERS: 19US FAERS
15Chest discomfortFAERS: 18
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
16Product quality issueFAERS: 18US FAERS
17ArthralgiaFAERS: 17SIDER
US FAERS
18InfluenzaFAERS: 17SIDER
US FAERS
19Intentional product misuseFAERS: 17US FAERS
20Adverse eventFAERS: 16US FAERS
21SomnolenceFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
22Myocardial InfarctionFAERS: 13
Canada Vigilance: 1
16464313
20159412
CTD
SIDER
Canada Vigilance
US FAERS
23Activities of daily living impairedFAERS: 12US FAERS
24Chest PainFAERS: 12
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
25Oropharyngeal painFAERS: 12SIDER
US FAERS
26SinusitisFAERS: 12OFFSIDES
SIDER
US FAERS
27StressFAERS: 12OFFSIDES
US FAERS
28MyalgiaFAERS: 11SIDER
US FAERS
29Throat irritationFAERS: 11US FAERS
30Cerebrovascular accidentFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
31Memory impairmentFAERS: 10US FAERS
32Abdominal discomfortFAERS: 9
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
33Product substitution issueFAERS: 9
Canada Vigilance: 4
Canada Vigilance
US FAERS
34RetchingFAERS: 9US FAERS
35Weight decreasedFAERS: 9US FAERS
36AstheniaFAERS: 8SIDER
US FAERS
37Cerebral InfarctionFAERS: 8US FAERS
38HypersensitivityFAERS: 8SIDER
US FAERS
39Impaired work abilityFAERS: 8US FAERS
40OverdoseFAERS: 8US FAERS
41ToothacheFAERS: 8US FAERS
42BronchitisFAERS: 7SIDER
US FAERS
43Cluster HeadacheFAERS: 7US FAERS
44PalpitationsFAERS: 7SIDER
US FAERS
45Atrial FibrillationFAERS: 6SIDER
US FAERS
46Depressed moodFAERS: 6OFFSIDES
US FAERS
47Drug DependenceFAERS: 6US FAERS
48Lip swellingFAERS: 6US FAERS
49Multiple SclerosisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
50Muscle tightnessFAERS: 6OFFSIDES
SIDER
US FAERS
51TachycardiaFAERS: 6SIDER
US FAERS
52Toxicity to various agentsFAERS: 6US FAERS
53nervous system disorderFAERS: 6SIDER
US FAERS
54Burning sensationFAERS: 5OFFSIDES
SIDER
US FAERS
55DisorientationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
56Drug administration errorFAERS: 5US FAERS
57Drug exposure during pregnancyFAERS: 5OFFSIDES
US FAERS
58HypotensionFAERS: 59489607CTD
US FAERS
59Limb injuryFAERS: 5US FAERS
60Musculoskeletal stiffnessFAERS: 5
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
61PruritusFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
62Therapeutic response unexpectedFAERS: 5US FAERS
63TremorFAERS: 5SIDER
US FAERS
64Wrong drug administeredFAERS: 5US FAERS
65Wrong technique in drug usage processFAERS: 5US FAERS
66AmnesiaFAERS: 4SIDER
US FAERS
67Angina PectorisFAERS: 4SIDER
US FAERS
68AphasiaFAERS: 4US FAERS
69BedriddenFAERS: 4OFFSIDES
US FAERS
70ChillsFAERS: 4SIDER
US FAERS
71DehydrationFAERS: 4OFFSIDES
SIDER
US FAERS
72DiscomfortFAERS: 4SIDER
US FAERS
73Drug dispensing errorFAERS: 4US FAERS
74Eye painFAERS: 4SIDER
US FAERS
75Facial PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
76FibromyalgiaFAERS: 4OFFSIDES
US FAERS
77FlatulenceFAERS: 4US FAERS
78Joint injuryFAERS: 4US FAERS
79LethargyFAERS: 4US FAERS
80Maternal exposure during pregnancyFAERS: 4US FAERS
81Medication overuse headacheFAERS: 4SIDER
US FAERS
82MicrophthalmosFAERS: 4US FAERS
83Migraine with AuraFAERS: 4US FAERS
84Nasal discomfortFAERS: 4US FAERS
85Neck PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
86NephrolithiasisFAERS: 4OFFSIDES
US FAERS
87NervousnessFAERS: 4SIDER
US FAERS
88PneumoniaFAERS: 4SIDER
US FAERS
89Product dose omissionFAERS: 4US FAERS
90Sinus headacheFAERS: 4US FAERS
91Sleep disorder due to general medical condition, insomnia typeFAERS: 4US FAERS
92SneezingFAERS: 4US FAERS
93Transaminases increasedFAERS: 4US FAERS
94UrticariaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
95VasospasmFAERS: 4OFFSIDES
SIDER
US FAERS
96Abdominal PainFAERS: 3OFFSIDES
SIDER
US FAERS
97AnxietyFAERS: 3OFFSIDES
SIDER
US FAERS
98AphagiaFAERS: 3US FAERS
99AsthmaFAERS: 3OFFSIDES
US FAERS
100Back PainFAERS: 3SIDER
US FAERS
101Carotid artery occlusionFAERS: 3OFFSIDES
US FAERS
102Circumstance or information capable of leading to medication errorFAERS: 3US FAERS
103DisabilityFAERS: 3US FAERS
104Drug abuseFAERS: 3US FAERS
105Drug effect incompleteFAERS: 3US FAERS
106Drug prescribing errorFAERS: 3US FAERS
107EpilepsyFAERS: 3US FAERS
108EpistaxisFAERS: 3OFFSIDES
SIDER
US FAERS
109Expired product administeredFAERS: 3US FAERS
110Head discomfortFAERS: 3US FAERS
111HyperacusisFAERS: 3SIDER
US FAERS
112HypokinesiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
113Impaired driving abilityFAERS: 3OFFSIDES
US FAERS
114Incorrect route of drug administrationFAERS: 3US FAERS
115Intervertebral Disc DegenerationFAERS: 3OFFSIDES
US FAERS
116Joint swellingFAERS: 3US FAERS
117Limb discomfortFAERS: 3OFFSIDES
US FAERS
118Medication ErrorFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
119Multiple MyelomaFAERS: 3US FAERS
120Optic NeuritisFAERS: 3US FAERS
121Pericardial effusionFAERS: 3US FAERS
122PhotophobiaFAERS: 3SIDER
US FAERS
123Product use issueFAERS: 3US FAERS
124Rebound effectFAERS: 3OFFSIDES
US FAERS
125Suicide attemptFAERS: 3US FAERS
126SyncopeFAERS: 3SIDER
US FAERS
127ThrombosisFAERS: 3US FAERS
128ThyroiditisFAERS: 3US FAERS
129Ventricular FibrillationFAERS: 3SIDER
US FAERS
130Visual ImpairmentFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
131Accidental overdoseFAERS: 2OFFSIDES
US FAERS
132AcneFAERS: 2US FAERS
133Acute myocardial infarctionFAERS: 2US FAERS
134Alanine Aminotransferase IncreasedFAERS: 2US FAERS
135Animal biteFAERS: 2US FAERS
136Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
137Autonomic nervous system imbalanceFAERS: 2US FAERS
138Biliary DyskinesiaFAERS: 2US FAERS
139Blood creatine phosphokinase increasedFAERS: 2OFFSIDES
US FAERS
140Blood lactate dehydrogenase increasedFAERS: 2US FAERS
141Cardiac ArrestFAERS: 2US FAERS
142Cerebellar infarctionFAERS: 2OFFSIDES
US FAERS
143Cerebral artery occlusionFAERS: 2US FAERS
144Choking sensationFAERS: 2OFFSIDES
US FAERS
145CholestasisFAERS: 2US FAERS
146Coronary Artery DiseaseFAERS: 2US FAERS
147CryingFAERS: 2US FAERS
148Deep Vein ThrombosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
149Depressed Level of ConsciousnessFAERS: 2US FAERS
150Drug abuserFAERS: 2OFFSIDES
US FAERS
151Drug effect delayedFAERS: 2US FAERS
152DysarthriaFAERS: 2US FAERS
153DysphoniaFAERS: 2US FAERS
154EmbolismFAERS: 2OFFSIDES
US FAERS
155Emotional disorderFAERS: 2US FAERS
156Epigastric discomfortFAERS: 2US FAERS
157Erectile dysfunctionFAERS: 2US FAERS
158FlushingFAERS: 2US FAERS
159Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
160General physical health deteriorationFAERS: 2US FAERS
161HemiplegiaFAERS: 2US FAERS
162HepatitisFAERS: 2OFFSIDES
US FAERS
163Hypertensive crisisFAERS: 2US FAERS
164Intercepted drug prescribing errorFAERS: 2US FAERS
165Joint stiffnessFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
166LymphadenopathyFAERS: 2SIDER
US FAERS
167MeningorrhagiaFAERS: 2OFFSIDES
US FAERS
168Meniscus injuryFAERS: 2US FAERS
169Multiple sclerosis relapseFAERS: 2US FAERS
170Muscle FatigueFAERS: 2US FAERS
171NeuralgiaFAERS: 2OFFSIDES
US FAERS
172OsteoporosisFAERS: 2SIDER
US FAERS
173PallorFAERS: 2OFFSIDES
US FAERS
174Pharmaceutical product complaintFAERS: 2US FAERS
175Pharyngolaryngeal PainFAERS: 2OFFSIDES
US FAERS
176Product taste abnormalFAERS: 2US FAERS
177Pulmonary EmbolismFAERS: 2US FAERS
178Retinal Artery OcclusionFAERS: 2US FAERS
179Retinal Vein OcclusionFAERS: 2OFFSIDES
US FAERS
180Rheumatoid ArthritisFAERS: 2US FAERS
181Serotonin SyndromeFAERS: 2SIDER
US FAERS
182SpondylitisFAERS: 2US FAERS
183Temperature intoleranceFAERS: 2US FAERS
184Urinary tract infectionFAERS: 2SIDER
US FAERS
185Vertebral Artery DissectionFAERS: 2US FAERS
186VertigoFAERS: 2SIDER
US FAERS
187Wrong patient received medicationFAERS: 2US FAERS
188Wrong technique in product usage processFAERS: 2US FAERS
189jaundiceFAERS: 2SIDER
US FAERS
190AbasiaFAERS: 1US FAERS
191Accidental exposure to productFAERS: 1US FAERS
192Accidental exposure to product by childFAERS: 1US FAERS
193Accidental exposureFAERS: 1US FAERS
194Acute Coronary SyndromeFAERS: 119538745CTD
SIDER
US FAERS
195Adenoidal disorderFAERS: 1US FAERS
196Allergic reaction to excipientFAERS: 1US FAERS
197Altered state of consciousnessFAERS: 1US FAERS
198Amphetamines positiveFAERS: 1US FAERS
199Anal FissureFAERS: 1US FAERS
200Anaphylactic shockFAERS: 1SIDER
US FAERS
201AngiodysplasiaFAERS: 1US FAERS
202AngioedemaFAERS: 1OFFSIDES
SIDER
US FAERS
203Angle Closure GlaucomaFAERS: 1US FAERS
204AnhedoniaFAERS: 1US FAERS
205Ankle FractureFAERS: 1US FAERS
206AnosmiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
207ArthritisFAERS: 1OFFSIDES
SIDER
US FAERS
208ArthropathyFAERS: 1SIDER
US FAERS
209AuraFAERS: 1US FAERS
210Back disorderFAERS: 1US FAERS
211Bacterial test positiveFAERS: 1US FAERS
212BiopsyFAERS: 1US FAERS
213Bladder discomfortFAERS: 1US FAERS
214BlindnessFAERS: 1US FAERS
215Blood alkaline phosphatase increasedFAERS: 1SIDER
US FAERS
216Blood cholesterol abnormalFAERS: 1US FAERS
217Blood creatinine decreasedFAERS: 1US FAERS
218Blood potassium decreasedFAERS: 1US FAERS
219Breast CystFAERS: 1US FAERS
220BronchospasmFAERS: 1SIDER
US FAERS
221CataplexyFAERS: 1US FAERS
222CataractFAERS: 1US FAERS
223CellulitisFAERS: 1OFFSIDES
SIDER
US FAERS
224Central nervous system lesionFAERS: 1US FAERS
225Cerebral disorderFAERS: 1US FAERS
226CheilitisFAERS: 1US FAERS
227CholelithiasisFAERS: 1US FAERS
228ClumsinessFAERS: 1US FAERS
229Cold sweatFAERS: 1US FAERS
230Congenital diaphragmatic herniaFAERS: 1US FAERS
231Diastolic dysfunctionFAERS: 1US FAERS
232Disease recurrenceFAERS: 1US FAERS
233DissociationFAERS: 1US FAERS
234Drug resistanceFAERS: 1US FAERS
235Dry skinFAERS: 1OFFSIDES
US FAERS
236DysgraphiaFAERS: 1US FAERS
237DyspepsiaFAERS: 1SIDER
US FAERS
238DysuriaFAERS: 1OFFSIDES
US FAERS
239Echocardiogram abnormalFAERS: 1US FAERS
240Economic problemFAERS: 1US FAERS
241Ejection Fraction DecreasedFAERS: 1US FAERS
242Electrocardiogram changeFAERS: 1US FAERS
243Emotional distressFAERS: 1OFFSIDES
US FAERS
244Endodontic procedureFAERS: 1OFFSIDES
US FAERS
245Erythema MultiformeFAERS: 1US FAERS
246Euphoric moodFAERS: 1SIDER
US FAERS
247Expired drug administeredFAERS: 1US FAERS
248Extremity necrosisFAERS: 1US FAERS
249Eyelid margin crustingFAERS: 1US FAERS
250Feeling ColdFAERS: 1SIDER
US FAERS
251Fibrin D dimer increasedFAERS: 1US FAERS
252Flank PainFAERS: 1US FAERS
253Food PoisoningFAERS: 1US FAERS
254FrustrationFAERS: 1US FAERS
255Gastroenteritis norovirusFAERS: 1US FAERS
256Gastrointestinal hypermotilityFAERS: 1US FAERS
257GlaucomaFAERS: 1US FAERS
258HemiparesisFAERS: 1US FAERS
259HepatotoxicityFAERS: 1US FAERS
260HerniaFAERS: 1US FAERS
261Hormone level abnormalFAERS: 1US FAERS
262HypothyroidismFAERS: 1US FAERS
263HypoxiaFAERS: 1US FAERS
264ImmobileFAERS: 1OFFSIDES
US FAERS
265Impaired gastric emptyingFAERS: 1US FAERS
266ImpatienceFAERS: 1US FAERS
267Inappropriate affectFAERS: 1US FAERS
268Inappropriate schedule of drug administrationFAERS: 1OFFSIDES
US FAERS
269Incision site complicationFAERS: 1US FAERS
270InfertilityFAERS: 1US FAERS
271Insurance issueFAERS: 1US FAERS
272Intervertebral disc disorderFAERS: 1OFFSIDES
US FAERS
273Irritable Bowel SyndromeFAERS: 1US FAERS
274Joint InstabilityFAERS: 1US FAERS
275Joint Range of Motion DecreasedFAERS: 1US FAERS
276Labile hypertensionFAERS: 1US FAERS
277Leukocytoclastic vasculitisFAERS: 1US FAERS
278LeukopeniaFAERS: 1SIDER
US FAERS
279Ligament ruptureFAERS: 1US FAERS
280Lyme DiseaseFAERS: 1US FAERS
281LymphomaFAERS: 1US FAERS
282Macular degenerationFAERS: 1US FAERS
283Mediastinal FibrosisFAERS: 1US FAERS
284MenopauseFAERS: 1US FAERS
285MenorrhagiaFAERS: 1SIDER
US FAERS
286Motion SicknessFAERS: 1US FAERS
287Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
288MydriasisFAERS: 1US FAERS
289Myoclonic EpilepsyFAERS: 1US FAERS
290MyosclerosisFAERS: 1US FAERS
291NarcolepsyFAERS: 1US FAERS
292Nephrotic SyndromeFAERS: 1US FAERS
293Nerve injuryFAERS: 1US FAERS
294No reaction on previous exposure to drugFAERS: 1US FAERS
295Opiates positiveFAERS: 1US FAERS
296Optic NeuropathyFAERS: 1US FAERS
297Oral painFAERS: 1US FAERS
298Oropharyngeal discomfortFAERS: 1SIDER
US FAERS
299Osmolar gap increasedFAERS: 1US FAERS
300PancreatitisFAERS: 1OFFSIDES
SIDER
US FAERS
301Panic DisorderFAERS: 1US FAERS
302Paradoxical drug reactionFAERS: 1US FAERS
303Pelvic PainFAERS: 1US FAERS
304Pelvic massFAERS: 1US FAERS
305Peripheral swellingFAERS: 1US FAERS
306PhonophobiaFAERS: 1OFFSIDES
US FAERS
307Physical disabilityFAERS: 1US FAERS
308PolyuriaFAERS: 1SIDER
US FAERS
309Post-Traumatic Stress DisorderFAERS: 1US FAERS
310Post-traumatic painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
311Precancerous cells presentFAERS: 1US FAERS
312PresyncopeFAERS: 1US FAERS
313Product formulation issueFAERS: 1US FAERS
314Product packaging quantity issueFAERS: 1US FAERS
315Product solubility abnormalFAERS: 1US FAERS
316ProteinuriaFAERS: 1US FAERS
317PseudomyopiaFAERS: 1US FAERS
318Reaction to drug excipientsFAERS: 1US FAERS
319Reaction to food additiveFAERS: 1US FAERS
320RegurgitationFAERS: 1US FAERS
321Respiratory FailureFAERS: 1OFFSIDES
US FAERS
322Respiratory distressFAERS: 1US FAERS
323Restless Legs SyndromeFAERS: 1US FAERS
324RhinalgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
325Rotator cuff syndromeFAERS: 1US FAERS
326SchizophreniaFAERS: 1OFFSIDES
US FAERS
327Secretion dischargeFAERS: 1US FAERS
328Septic ShockFAERS: 1OFFSIDES
US FAERS
329ShockFAERS: 1SIDER
US FAERS
330Sinus painFAERS: 1US FAERS
331Skin UlcerFAERS: 1US FAERS
332Skin reactionFAERS: 1US FAERS
333Sleep disorder due to a general medical conditionFAERS: 1US FAERS
334Somatoform DisorderFAERS: 1US FAERS
335SomnambulismFAERS: 1US FAERS
336Spinal column stenosisFAERS: 1US FAERS
337StomatitisFAERS: 1SIDER
US FAERS
338Stress at workFAERS: 1US FAERS
339Supraventricular tachycardiaFAERS: 1US FAERS
340SwellingFAERS: 1US FAERS
341TachyarrhythmiaFAERS: 1US FAERS
342Tension HeadacheFAERS: 1US FAERS
343Therapeutic response delayedFAERS: 1US FAERS
344TinnitusFAERS: 1OFFSIDES
SIDER
US FAERS
345Tooth InfectionFAERS: 1US FAERS
346TorticollisFAERS: 1US FAERS
347TrismusFAERS: 1US FAERS
348Troponin I increasedFAERS: 1US FAERS
349Ultrasound antenatal screenFAERS: 1OFFSIDES
US FAERS
350Unevaluable eventFAERS: 1US FAERS
351Unresponsive to stimuliFAERS: 1US FAERS
352Urinary RetentionFAERS: 1US FAERS
353Vertebral artery thrombosisFAERS: 1US FAERS
354Violence-related symptomFAERS: 1US FAERS
355Visual disturbanceFAERS: 1OFFSIDES
US FAERS
356Abdominal adhesionsOFFSIDES
357Acid refluxOFFSIDES
358Acute migraineSIDER
359Acute sinusitisOFFSIDES
360AgitationSIDER
361AkathisiaSIDER
362AmblyopiaSIDER
363AmenorrheaOFFSIDES
364Ammonia increasedOFFSIDES
365Anaphylactoid ReactionSIDER
366AnhidrosisOFFSIDES
367AnorexiaSIDER
368AnorgasmiaOFFSIDES
369Anoxic EncephalopathyOFFSIDES
370Antiphospholipid antibodies positiveOFFSIDES
371Aortic AneurysmOFFSIDES
372Apallic syndromeOFFSIDES
373ApathySIDER
374AtaxiaOFFSIDES
SIDER
375AtelectasisOFFSIDES
376Autoimmune hepatitisOFFSIDES
377AutomatismOFFSIDES
378Bipolar DisorderOFFSIDES
379Bipolar II disorderOFFSIDES
380Bladder painSIDER
381Blood GlucoseOFFSIDES
382Blood cholesterolOFFSIDES
383Blood homocysteineOFFSIDES
384Blood sodiumOFFSIDES
385Blood triglycerides increasedOFFSIDES
386Bone marrow depressionOFFSIDES
387Bone painSIDER
388BradycardiaSIDER
389Bronchial ObstructionOFFSIDES
390BruxismOFFSIDES
391Cerebrovascular InsufficiencyOFFSIDES
392Ceruloplasmin increasedOFFSIDES
393Chemical and Drug Induced Liver Injury31129132CTD
394Chest heavinessSIDER
395Chest pressureSIDER
396Chest tightnessSIDER
397Chest wall painOFFSIDES
398CholecystitisOFFSIDES
399Chronic Fatigue SyndromeOFFSIDES
400Chronic sinusitisOFFSIDES
401Chronic ulcerative colitisOFFSIDES
402Circumoral paresthesiaSIDER
403ColitisSIDER
404Complications of maternal exposure to therapeutic drugsOFFSIDES
405Congenital intestinal malformationOFFSIDES
406ConjunctivitisSIDER
407ConstipationSIDER
408Contact DermatitisOFFSIDES
409ContractureOFFSIDES
410Cramps of lower extremitiesSIDER
411Culture wound positiveOFFSIDES
412CyanosisSIDER
413CystitisSIDER
414CystOFFSIDES
415Delusional disorder, unspecified typeOFFSIDES
416Depressive disorder11167903CTD
417DermatitisSIDER
418Diabetes InsipidusOFFSIDES
419Diabetes mellitus inadequate controlOFFSIDES
420DiplopiaSIDER
421Dissociative disorderOFFSIDES
422Drug addictOFFSIDES
423Drug ineffective for unapproved indicationCanada Vigilance: 1Canada Vigilance
424Drug withdrawal headacheOFFSIDES
425Ear discomfortOFFSIDES
426EcchymosisSIDER
427EczemaSIDER
428Electrocardiogram QT interval abnormalOFFSIDES
429Electrocardiogram ST segment abnormalOFFSIDES
430Electrocardiogram abnormalSIDER
431Electromyogram abnormalOFFSIDES
432EncephalitisOFFSIDES
433EosinophiliaSIDER
434EructationSIDER
435ErythemaSIDER
436Esophageal StenosisOFFSIDES
437Eustachian tube disorderOFFSIDES
438Eye InfectionOFFSIDES
439Flat affectSIDER
440Gastric ulcerOFFSIDES
441GastritisSIDER
442GastroenteritisSIDER
443Gastrointestinal PainSIDER
444Gastrointestinal carcinomaSIDER
445GingivitisSIDER
446Granulomatous liver diseaseOFFSIDES
447Heat StrokeOFFSIDES
448Heparin-induced thrombocytopeniaOFFSIDES
449Hepatic Vein ThrombosisOFFSIDES
450Hepatic necrosisOFFSIDES
451Hepatitis COFFSIDES
452Hepatomegaly31129132CTD
453HidradenitisOFFSIDES
454HistoplasmosisOFFSIDES
455HyperkinesiaSIDER
456HyperthyroidismSIDER
457HyperventilationSIDER
458HypospadiasOFFSIDES
459Infarction16615676CTD
SIDER
460InfectionSIDER
461Injection site infectionOFFSIDES
462Insulin ResistanceOFFSIDES
463Intestinal ObstructionSIDER
464Kidney Diseases16615676CTD
465LacrimationSIDER
466LaryngitisSIDER
467Liver neoplasms31129132CTD
468Lymphocyte percentage decreasedOFFSIDES
469Lymphoid tissue hyperplasiaOFFSIDES
470Manic psychosisSIDER
471Medical device complicationOFFSIDES
472Mental status changesOFFSIDES
473Mesenteric artery stenosisOFFSIDES
474MetrorrhagiaSIDER
475MicroalbuminuriaOFFSIDES
476Middle insomniaOFFSIDES
477Migraine Disorders

View details

CTD
478Mixed Connective Tissue DiseaseOFFSIDES
479Mood swingsSIDER
480Muscle Cramp16239765CTD
481Muscle necrosisOFFSIDES
482Muscle relaxant therapySIDER
483Muscle strainOFFSIDES
484Musculoskeletal PainCanada Vigilance: 1Canada Vigilance
485Myasthenia GravisOFFSIDES
486MyokymiaOFFSIDES
487Nasal sinus drainageOFFSIDES
488Neck tightnessSIDER
489NecrosisSIDER
490Neonatal respiratory depressionCanada Vigilance: 1Canada Vigilance
491NeuropathySIDER
492NoduleOFFSIDES
493OligohydramniosOFFSIDES
494OsteomyelitisOFFSIDES
495Pancreatic PseudocystOFFSIDES
496Patellofemoral Pain SyndromeOFFSIDES
497PharyngitisSIDER
498PhlebitisOFFSIDES
499Pilonidal cyst congenitalOFFSIDES
500Placental InsufficiencyOFFSIDES
501PneumothoraxOFFSIDES
502Post procedural discomfortOFFSIDES
503Prinzmetal's variant angina20159412CTD
504Proctitis herpesOFFSIDES
505ProctocolitisOFFSIDES
506Product complaintCanada Vigilance: 1Canada Vigilance
507Product dispensing errorCanada Vigilance: 1Canada Vigilance
508Product physical issueCanada Vigilance: 1Canada Vigilance
509PseudocystOFFSIDES
510Pulmonary malformationOFFSIDES
511Purulent dischargeOFFSIDES
512PyelonephritisSIDER
513Reaction aggravationSIDER
514Rectal tenesmusOFFSIDES
515Renal painSIDER
516Retinal VasculitisOFFSIDES
517Retroperitoneal fibrosisOFFSIDES
518RhinitisSIDER
519Rocky Mountain Spotted FeverOFFSIDES
520ScotomaSIDER
521Secondary hypothyroidismOFFSIDES
522Splenic InfarctionSIDER
523Stevens-Johnson SyndromeOFFSIDES
524StiffnessSIDER
525Subcutaneous AbscessOFFSIDES
526Sweat gland infectionOFFSIDES
527SweatingSIDER
528SynovitisOFFSIDES
529Takotsubo Cardiomyopathy24100257CTD
530Tardive DyskinesiaSIDER
531TenosynovitisSIDER
532TensionSIDER
533TetanySIDER
534Therapy non-responderOFFSIDES
535ThirstSIDER
536ThrombocytopeniaSIDER
537ThrombophlebitisOFFSIDES
SIDER
538Tinea crurisOFFSIDES
539Tooth ExtractionOFFSIDES
540Transient Cerebral IschemiaSIDER
541UlcerSIDER
542Ultrasound abdomen abnormalOFFSIDES
543Unexpected therapeutic drug effectOFFSIDES
544Urine output increasedSIDER
545Uterine fibroids enlargedSIDER
546VIIth nerve paralysisOFFSIDES
547Vasodilation procedureSIDER
548VasodilationSIDER
549Vocal cord cystOFFSIDES
550YawningSIDER
551carbuncleOFFSIDES
552effusionOFFSIDES
553fibromaOFFSIDES
554furuncleOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.